Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 11, 2006

Bioactive Material Completes Proof-of-Concept Studies

  • NovaThera and Pharming completed proof-of-concept studies designed to develop a new generation of bioactive materials. These materials are based on a fusion of the two companies’ technologies —TheraGlass™ (a nonceramic glass) and recombinant human proteins.

    TheraGlass-rH (TheraGlass with recombinant human proteins) has the potential to extend the therapeutic potential from transgenic technologies into the arena of medical devices and materials technologies, the companies report. The new materials can be used for the localized delivery of therapeutic proteins and for developing devices, such as stents and catheters.

    The initial focus is on stents containing materials able to release recombinant human proteins, such as collagen, fibrinogen, lactoferrin, and C1 inhibitor.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »